This topic contains a solution. Click here to go to the answer

Author Question: When a patient who is started on ACE-inhibitor therapy is followed, an important laboratory ... (Read 77 times)

lracut11

  • Hero Member
  • *****
  • Posts: 536
When a patient who is started on ACE-inhibitor therapy is followed, an important laboratory parameter to monitor is the serum:
 
  1. troponin level.
  2. neutrophil count.
  3. erythrocyte sedimentation rate.
  4. uric acid.

Question 2

The nurse counsels a patient beginning therapy on an angiotensin IIreceptor blocker (valsartan). A side effect that should be included in the drug education is:
 
  1. cough.
  2. heart failure.
  3. dehydration.
  4. angioedema.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ksanderson1296

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

Correct Answer: 2

Answer to Question 2

Correct Answer: 4




lracut11

  • Member
  • Posts: 536
Reply 2 on: Jul 23, 2018
Gracias!


skipfourms123

  • Member
  • Posts: 343
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Everyone has one nostril that is larger than the other.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

For a complete list of videos, visit our video library